📊 QCLS Key Takeaways
Is Q/C Technologies, Inc.. (QCLS) a Good Investment?
Q/C Technologies is a biodiagnostic company in severe financial distress with negative gross margins (-52.1%), indicating broken product economics. With only $1.1M cash and -$5.0M free cash flow, the company faces imminent liquidity pressure within months. Minimal and declining revenue ($361.6K, -5.3% YoY) combined with mounting losses signals bankruptcy risk without substantial capital injection or operational restructuring.
Q/C Technologies, Inc.. Key Strengths (QCLS)
- No long-term debt provides financial flexibility and restructuring options
- Stockholders' equity of $20.7M offers balance sheet cushion and asset value
- Net loss improved 22.4% YoY indicating some operational improvement trajectory
QCLS Stock Risks: Q/C Technologies, Inc.. Investment Risks
- Negative gross margin (-52.1%) demonstrates broken unit economics and fundamentally unsustainable business model
- Critical liquidity crisis with only $1.1M cash against -$5.0M annual free cash flow burn rate
- Minimal and declining revenue combined with operating losses indicates failed market commercialization and bankruptcy risk within 2-3 quarters
Key Metrics to Watch
- Quarterly cash position and estimated runway
- Gross margin improvement toward positive contribution
- Revenue acceleration and customer adoption trends
- Operating cash flow inflection to positive
Q/C Technologies, Inc.. (QCLS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.71x current ratio provides a solid financial cushion.
QCLS Profit Margin, ROE & Profitability Analysis
QCLS vs Healthcare Sector: How Q/C Technologies, Inc.. Compares
How Q/C Technologies, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Q/C Technologies, Inc.. Stock Overvalued? QCLS Valuation Analysis 2026
Based on fundamental analysis, Q/C Technologies, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Q/C Technologies, Inc.. Balance Sheet: QCLS Debt, Cash & Liquidity
QCLS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Q/C Technologies, Inc..'s revenue has declined by 62% over the 5-year period, indicating business contraction. The most recent EPS of $-1,080.87 indicates the company is currently unprofitable.
QCLS Revenue Growth, EPS Growth & YoY Performance
QCLS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2020 | -$1.9K | -$776.8K | N/A |
| Q1 2020 | $363.5K | -$887.6K | N/A |
| Q3 2019 | $420.8K | -$794.9K | N/A |
| Q2 2019 | $464.5K | -$776.8K | N/A |
| Q1 2019 | $302.5K | -$887.6K | N/A |
| Q3 2018 | $557.1K | -$1.2M | N/A |
| Q2 2018 | $526.6K | -$818.0K | N/A |
| Q1 2018 | $302.5K | -$1.3M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Q/C Technologies, Inc.. Dividends, Buybacks & Capital Allocation
QCLS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Q/C Technologies, Inc.. (CIK: 0001321834)
📋 Recent SEC Filings
❓ Frequently Asked Questions about QCLS
What is the AI rating for QCLS?
Q/C Technologies, Inc.. (QCLS) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are QCLS's key strengths?
Claude: No long-term debt provides financial flexibility and restructuring options. Stockholders' equity of $20.7M offers balance sheet cushion and asset value.
What are the risks of investing in QCLS?
Claude: Negative gross margin (-52.1%) demonstrates broken unit economics and fundamentally unsustainable business model. Critical liquidity crisis with only $1.1M cash against -$5.0M annual free cash flow burn rate.
What is QCLS's revenue and growth?
Q/C Technologies, Inc.. reported revenue of $361.6K.
Does QCLS pay dividends?
Q/C Technologies, Inc.. pays dividends, with $1.4M distributed to shareholders in the trailing twelve months.
Where can I find QCLS SEC filings?
Official SEC filings for Q/C Technologies, Inc.. (CIK: 0001321834) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is QCLS's EPS?
Q/C Technologies, Inc.. has a diluted EPS of $-0.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is QCLS's fundamental grade?
Based on our AI fundamental analysis in May 2026, Q/C Technologies, Inc.. has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is QCLS stock overvalued or undervalued?
Valuation metrics for QCLS: ROE of -6.0% (sector avg: 15%), net margin of -343.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is QCLS's AI grade for 2026?
Our dual AI analysis gives Q/C Technologies, Inc.. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is QCLS's free cash flow?
Q/C Technologies, Inc..'s operating cash flow is $-3.3M, with capital expenditures of $1.8M. FCF margin is -1,392.8%.
How does QCLS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -343.7% (avg: 12%), ROE -6.0% (avg: 15%), current ratio 3.71 (avg: 2).